0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-09-03 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15934000 2024-09-03 2024-10-31 15934000 2024-10-31 15934000 2024-09-02 15934000 bus:LeadAgentIfApplicable 2024-09-03 2024-10-31 15934000 bus:Director1 2024-09-03 2024-10-31 15934000 core:ShareCapital 2024-10-31 15934000 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-10-31 15934000 core:CostValuation core:Non-currentFinancialInstruments 2024-10-31 15934000 core:Non-currentFinancialInstruments 2024-10-31 15934000 bus:SmallEntities 2024-09-03 2024-10-31 15934000 bus:AuditExemptWithAccountantsReport 2024-09-03 2024-10-31 15934000 bus:SmallCompaniesRegimeForAccounts 2024-09-03 2024-10-31 15934000 bus:PrivateLimitedCompanyLtd 2024-09-03 2024-10-31 15934000 bus:AbridgedAccounts 2024-09-03 2024-10-31

STATEMENT OF CONSENT TO PREPARE ABRIDGED FINANCIAL STATEMENTS

All of the members of Zanta Healthcare Holdings Limited have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the period ending 31 October 2024 in accordance with Section 444(2A) of the Companies Act 2006.
COMPANY REGISTRATION NUMBER: 15934000

ZANTA HEALTHCARE HOLDINGS LIMITED

FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS

FOR THE PERIOD ENDED

31 October 2024

ZANTA HEALTHCARE HOLDINGS LIMITED

REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ABRIDGED FINANCIAL STATEMENTS OF ZANTA HEALTHCARE HOLDINGS LIMITED

PERIOD FROM 3 SEPTEMBER 2024 TO 31 OCTOBER 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of Zanta Healthcare Holdings Limited for the period ended 31 October 2024, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.
LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors
Lifford Hall Lifford Lane Kings Norton Birmingham B30 3JN
12 May 2026

ZANTA HEALTHCARE HOLDINGS LIMITED

ABRIDGED STATEMENT OF FINANCIAL POSITION

31 October 2024

| 31 Oct 24
Note | £ | £

Fixed assets

Investments | 4 |  | 50

Current assets

Cash at bank and in hand | 50 |
| ------------ |
Net current assets |  | 50
|  | ------------
Total assets less current liabilities |  | 100
|  | ------------

Capital and reserves

Called up share capital |  | 100
|  | ------------
Shareholder funds |  | 100
|  | ------------

These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the period ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
These abridged financial statements were approved by the board of directors and authorised for issue on 12 May 2026 , and are signed on behalf of the board by:

M Mhonyera |
Director |

Company registration number: 15934000

ZANTA HEALTHCARE HOLDINGS LIMITED

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

PERIOD FROM 3 SEPTEMBER 2024 TO 31 OCTOBER 2024
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lifford Hall, Lifford Lane, Kings Norton, Birmingham, B30 3JN.
2. Statement of Compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated abridged financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Investments

| £
Cost |
At 3 September 2024 | –
Additions | 50
| ------------
At 31 October 2024 | 50
| ------------
Impairment |
At 3 September 2024 and 31 October 2024 | –
| ------------
Carrying amount |
At 31 October 2024 | 50
| ------------

5. Controlling Party
The company was controlled by M Mhonyera throughout the period, by way of her holding of the entire issued share capital.